Back to search

Virginia Commonwealth University

INVESTIGATION OF PHENYLEPHRINE SULFATION AND INHIBITION USING A NOVEL HILIC ASSAY METHOD

Abstract

dc:description.abstract

Phenylephrine (PE) is the most commonly used over-the-counter nasal decongestant. The problem associated with phenylephrine is that it undergoes extensive first pass metabolism in the intestinal gut wall leading to its poor and variable oral bioavailability. This research project aims at developing strategies in order to increase the oral bioavailability of PE by co-administration of GRAS compounds. A HILIC assay method was developed to detect the parent drug, phenylephrine (PE) and its sulfate metabolite (PES).The enzyme kinetic studies were done with phenolic dietary or GRAS compounds using LS180 human intestinal cell model, recombinant SULT enzymes and human intestinal cytosol (HIC). From the screening studies done, one inhibitor was selected in order to study the mechanism of inhibition. In conclusion the studies done in vitro provided a basis in order to predict in vivo intrinsic clearance through the sulfation pathway.

Degree

thesis:*
Name thesis:degree_name
Master of Pharmaceutical Sciences
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Pharmaceutical Sciences

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Shah, Heta N
Contributors dc:contributor
  • Dr. Phillip Gerk
  • Dr. Jurgen Venitz
  • Dr. Joseph Ritter

Subjects

dc:subject × 4

Rights

dc:rights
Statement dc:rights
  • © The Author

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Shah, Heta N. INVESTIGATION OF PHENYLEPHRINE SULFATION AND INHIBITION USING A NOVEL HILIC ASSAY METHOD. Thesis thesis, https://doi.org/10.25772/HK7Q-TQ56